Cargando…
Role of renin–angiotensin system antagonists on long-term mortality post-percutaneous coronary intervention in reduced and preserved ejection fraction
AIMS: The use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II-receptor blockers (ARBs) post-myocardial infarction (MI) is supported by evidence based on trials performed in the thrombolysis era. This was prior to primary percutaneous coronary intervention (PCI) being routine pra...
Autores principales: | Prosser, Hamish C., Peck, Kah Yong, Dinh, Diem, Roberts, Louise, Chandrasekhar, Jaya, Brennan, Angela, Duffy, Stephen J., Clark, David, Ajani, Andrew E., Oqueli, Ernesto, Sebastian, Martin, Reid, Christopher M., Freeman, Melanie, Sajeev, Jithin K., Teh, Andrew W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242972/ https://www.ncbi.nlm.nih.gov/pubmed/35050405 http://dx.doi.org/10.1007/s00392-021-01985-x |
Ejemplares similares
-
Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry()
por: Fernando, Himawan, et al.
Publicado: (2021) -
Association of Body Mass Index and Extreme Obesity With Long‐Term Outcomes Following Percutaneous Coronary Intervention
por: Biswas, Sinjini, et al.
Publicado: (2019) -
Renin-Angiotensin Activation and Oxidative Stress in Early Heart Failure with Preserved Ejection Fraction
por: Negi, Smita I., et al.
Publicado: (2015) -
The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicity
por: Akolkar, Gauri, et al.
Publicado: (2015) -
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)